1. Home
  2. BRAG vs SCLX Comparison

BRAG vs SCLX Comparison

Compare BRAG & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bragg Gaming Group Inc.

BRAG

Bragg Gaming Group Inc.

HOLD

Current Price

$1.62

Market Cap

41.5M

Sector

Technology

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.35

Market Cap

48.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRAG
SCLX
Founded
2018
2011
Country
Canada
United States
Employees
N/A
34
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.5M
48.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BRAG
SCLX
Price
$1.62
$6.35
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
23.0K
92.4K
Earning Date
05-14-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$122.52
Revenue Next Year
$6.67
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$4.09
52 Week High
$4.82
$34.27

Technical Indicators

Market Signals
Indicator
BRAG
SCLX
Relative Strength Index (RSI) 32.77 39.05
Support Level $1.56 $6.20
Resistance Level $2.21 $8.18
Average True Range (ATR) 0.18 1.38
MACD -0.05 -0.32
Stochastic Oscillator 5.84 1.16

Price Performance

Historical Comparison
BRAG
SCLX

About BRAG Bragg Gaming Group Inc.

Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: